Tina-quant Cardiac high sensitivity CRP III

FDA 510(k) K260026 · Roche Diagnostics

Substantially Equivalent

510(k) numberK260026

Submission

Device name
Tina-quant Cardiac high sensitivity CRP III
Applicant
Roche Diagnostics
Indianapolis, IN, US
Received
January 5, 2026
Decision date
April 2, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5270
Specialty
Immunology

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Other 510(k)s with product code NQD

510(k)DeviceApplicantDecision
K233242Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)NQD · Traditional Siemens Healthcare Diagnostics, Inc.01/18/2024SE
K212559CardioPhase® hsCRPNQD · Special Siemens Healthcare Diagnostics Products GmbH12/16/2022SE
K173833CRP VarioNQD · Traditional SENTINEL CH. SpA09/27/2018SE
K081294Advia Chemistry Cardiophase High Sensitivity C-Reactive Protein (Hscrp), CalibratorsNQD · Traditional Siemens Healthcare Diagnostics, Inc.07/29/2008SE
K071002Immage Immunochemistry Systems High Sensitivity Cardiac C-Reactive Protein (CCRP) ReagentNQD · Traditional Beckman Coulter, Inc.06/21/2007SE
K070626Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) ReagentNQD · Traditional Beckman Coulter, Inc.05/04/2007SE
K071017Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests), L5KCRP…NQD · Special Siemens Medical Solutions Diagnostics05/02/2007SE
K062924Stratus CS Acute Care Cardiophase Hscrp TestpakNQD · Traditional Dade Behring, Inc.12/26/2006SE
K063057Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRPNQD · Abbreviated Diagnostic Products Corporation12/22/2006SE
K061802Dimension Vista Cardiophase Hscrp Flex Reagent Cartridge, Protein 2 Calibrator, Hscrp…NQD · Traditional Dade Behring, Inc.09/11/2006SE

More from Dade Behring, Inc.

510(k)DeviceDecision
K261686Elecsys Phospho-Tau (217P) PlasmaSET · Traditional 08/19/2026SE
K252323cobas pulse blood glucose monitoring systemPZI · Dual Track 06/12/2026SE
K252431Elecsys CalcitoninJKR · Traditional 04/24/2026SE
K252280Elecsys Anti-SARS-CoV-2 SQVP · Traditional 04/13/2026SE
K260049Elecsys Anti-HBc IgMSEI · Traditional 04/07/2026SE
K260048Elecsys Anti-HAV IgMLOL · Traditional 04/07/2026SE
K260046Elecsys Anti-HBc IISEI · Traditional 04/07/2026SE
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas…CEM · Traditional 02/12/2026SE
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR · Traditional 02/12/2026SE
K253839Elecsys Anti-SARS-CoV-2QVP · Special 12/17/2025SE

Questions and answers

When was Tina-quant Cardiac high sensitivity CRP III cleared by the FDA?

Tina-quant Cardiac high sensitivity CRP III (K260026) received a 510(k) decision of Substantially Equivalent on April 2, 2026, 87 days after the submission was received.

What is the product code of K260026?

The FDA product code is NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control, a Class II (moderate risk) device regulated under 21 CFR 866.5270.